Cerebral Protection System Market Size & Share Analysis - Growth Trends & Forecasts (2027 - 2032)

Market Trends and Insights

Clarets Sentinal System is Expected to Hold a Significant Share in the Market Over the Forecast Period

Clarets sentinel systems are indicated for use as an embolic protection device to capture and remove thrombus/debris while performing cardiovascular procedures. Thus, they are widely preferred in these procedures. Rising cardiovascular diseases and a high volume of cardiac surgeries are the factors responsible for the growth of the studied segment.

The significant adoption of sentinel cerebral protection systems is anticipated to drive the segment growth. For instance, an article published in JAMA Cardiology in October 2024, highlighted that in the PROTECTED TAVR trial, patients in the United States, Europe, and Australia were randomized to undergo transcatheter aortic valve replacement (TAVR) either with or without the Sentinel cerebral embolic protection (CEP) device. The trial aimed to assess the safety and efficacy of the device. While the primary endpoint - a reduction in overall strokes within 72 hours or at discharge with CEP use—was not achieved, a notable 62% relative reduction in disabling strokes was observed in a smaller subset (20 vs. 8 patients). This outcome highlights the potential of the Sentinel cerebral protection system to address critical needs in stroke prevention during TAVR procedures, which could drive growth in this segment as healthcare providers increasingly prioritize patient safety and outcomes.

The increasing clinical trials associated with sentinel cerebral protection system is anticipated to fuel the segment growth. For instance, in March 2024, Protembis, a German-based company, secured USD 30 million in Series B funding to launch a pivotal clinical trial for its intra-aortic filter device. The trial, a multi-center, randomized study, will evaluate the safety and effectiveness of the ProtEmbo Cerebral Embolic Protection device in 500 patients undergoing transcatheter aortic valve replacement (TAVR). Patients will be randomized to either receive the Boston Scientific Sentinel cerebral embolic protection (CEP) device or will not receive CEP. The inclusion of Boston Scientific's Sentinel CEP device in this trial highlights its established presence in the cerebral protection system market. The results of this study could further solidify the Sentinel system's position and potentially drive growth in this segment, as it continues to be a benchmark for comparison in clinical evaluations.

In conclusion, the Sentinel cerebral protection system segment is expected to witness significant growth due to its demonstrated potential in reducing disabling strokes during TAVR procedures and its established role as a benchmark in clinical trials.

North America is Expected to Hold a Significant Market Share Over the Forecast Period

North America is expected to hold a major share of the market owing to the rising incidence of cardiovascular and peripheral diseases and the growing geriatric population. The presence of key market players and the rising adoption of technological advancements are also expected to drive the market's growth.

The significant number of individuals affceted with cardiovascular diseases in the region is expected to drive the demands for cerebral protection systems used during cardiac surgical procedures, hence contributing to the market growth. For instance, the data published by the Canadian Heart Failure Society in May 2024 mentioned that over 100,000 Canadians receive a diagnosis of heart failure annually, and approximately 800,000 Canadians were living with the condition in 2023. Additionally, according to the October 2024 update of the United States Centers for Disease Control and Prevention (CDC), about 805 thousand people in the United States have a heart attack every year. Such a prevalence of cardiovascular diseases in this region is also expected to drive the market's growth.

Additionally, the high volume of cardiac surgeries in North American countries is expected to drive the growth of the market. For instance, an article published by Mass General Brigham Incorporated in November 2024, mentioned that over 900 thousand cardiac surgeries, including coronary bypass procedures, are conducted annually in the United States. Such a high volume of cardiac surgeries is expected to contribute to the growing demand for cerebral protection systems as these systems reduce cerebrovascular risks, thereby contributing to the growth of the market in this region over the forecast period.

The significant number of cardiac centres in the region is anticipated to drive the demand for cerebral protection system used during cardiac durgical procedures, boosting the market growth. For instance, an article published in Canadian Journal of Cardiology in June 2024, highlighted that Canada has 32 cardiac centers where adult cardiac surgeons practice, resulting in 0.79 centers per million people, a rate slightly higher than the global average of 0.73 per million. Thus, the region's strong healthcare infrastructure and increasing adoption of innovative medical devices, are expected to sustain the market's growth trajectory over the forecast period.

Thus, the increasing incidence of cardiovascular diseases, high cardiac surgical volume and strong healthcare infrastructure is expected to contribute to the growth of the market over the forecast period in North America.